NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/21/2024
Back to search
Official data from USPTO
SURMASIS PHARMACEUTICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SURMASIS PHARMACEUTICAL
ST13
US500000086135684Class
40
Filing
86135684
Registration
4604587
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
01/14/2025
Trademark type
Word
Nice classes
40
Filing date
12/05/2013
Registration date
09/16/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/21/2024
Last transaction
01/14/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/28/2014
First use in commerce
01/28/2014
Drawing code
4
Owner type
16
Owner location
DES MOINES, IA
Examiner
KON, ELISSA
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SURMASIS PHARMACEUTICAL, LLC
KATECHO, LLC
Katecho, Inc.
Representatives
Mark D. Hansing McKee, Voorhees & Sease, P.L.C.
Technical classification
Nice Classes
Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
custom manufacture of transdermal patches for others
Publications
History of USPTO decisions and trademark events.
39 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/21/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/21/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/21/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
09/11/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/16/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/07/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/25/2022
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
05/09/2020
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
05/09/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/08/2020
E15R
TEAS SECTION 15 RECEIVED
10/31/2019
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED
10/08/2019
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
10/08/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/08/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/20/2019
ES8R
TEAS SECTION 8 RECEIVED
09/20/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/16/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
09/16/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/01/2014
PUBO
PUBLISHED FOR OPPOSITION
07/01/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/11/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/24/2014
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
05/17/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/16/2014
IUAA
USE AMENDMENT ACCEPTED
05/16/2014
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
05/16/2014
IUAF
USE AMENDMENT FILED
05/16/2014
ALIE
ASSIGNED TO LIE
05/16/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/15/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/14/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/14/2014
EAAU
TEAS AMENDMENT OF USE RECEIVED
05/14/2014
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
03/18/2014
GPRA
PRIORITY ACTION E-MAILED
03/18/2014
CPRA
PRIORITY ACTION WRITTEN
03/18/2014
DOCK
ASSIGNED TO EXAMINER
03/17/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/17/2013
NWAP
NEW APPLICATION ENTERED
12/09/2013
Continuous trademark protection
Get notified about every new filing that threatens SURMASIS PHARMACEUTICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.